Evidence map›Paper›PMID 30157244›Full record

ArticlePloS one2018

Whole exome sequencing in Finnish families identifies new candidate genes for osteoarthritis.

Sini Skarp, Olli-Pekka Kämäräinen, Gong-Hong Wei, Eveliina Jakkula, Ilkka Kiviranta, Heikki Kröger, Juha Auvinen, Petri Lehenkari, Leena Ala-Kokko, Minna Männikkö

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Sini SkarpCenter for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.ORCID 0000-0003-2336-4221
Olli-Pekka KämäräinenFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Gong-Hong WeiFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Eveliina JakkulaFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Ilkka KivirantaDepartment of Orthopaedics and Traumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Heikki KrögerDepartment of Orthopaedics and Traumatology, Kuopio University Hospital and Kuopio Musculoskeletal Research Unit, University of Eastern Finland, Kuopio, Finland.
Juha AuvinenCenter for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
Petri LehenkariDepartment of Anatomy and Cell biology and Surgery Clinic, Medical Research Center, University of Oulu and Oulu University Hospital, Oulu, Finland.
Leena Ala-KokkoConnective Tissue Gene Tests, Allentown, PA, United States of America.
Minna MännikköCenter for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
University of Oulu · FIOulu University Hospital · FITissue Gene (United States) · USUniversity of Eastern Finland · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOsteoarthritis (OA) is the most common degenerative joint disease and one of the major causes of disability worldwide. It is a multifactorial disorder with a significant genetic component. The heritability of OA has been estimated to be 60% for hip OA and 39% for knee OA. Genetic factors behind OA are still largely unknown. Studying families with strong history of OA, facilitates examining the co-segregation of genetic variation and OA. The aim of this study was to identify new, rare genetic factors and novel candidate genes for OA.

methodsEight patients from three Finnish families with hip and knee OA were studied using whole exome sequencing. We focused on rare exonic variants with predicted pathogenicity and variants located in active promoter or strong enhancer regions. Expression of identified candidate genes were studied in bone and cartilage tissues and the observed variants were investigated using bioinformatic analyses.

resultsTwo rare variants co-segregated with OA in two families. In Family 8 a missense variant (c.628C>G, p.Arg210Gly) was observed in the OLIG3 gene that encodes a transcription factor known to be associated with rheumatoid arthritis and inflammatory polyarthritis. The Arg210Gly variant was estimated to be pathogenic by Polyphen-2 and Mutation taster and the locus is conserved among mammals. In Family 12 the observed variant (c.-127G>T) was located in the transcription start site of the FIP1L1 gene. FIP1L1 participates in the regulation of polyadenylation. The c.-127G>T is located in the transcription start site and may alter the DNA-binding of transcription factors. Both, OLIG3 and FIP1L1 were observed in human bone and cartilage.

conclusionThe identified variants revealed novel candidate genes for OA. OLIG3 and FIP1L1 have specific roles in transcription and may effect expression of other genes. Identified variants in these genes may thus have a role in the regulatory events leading to OA.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationAdultAgedAged, 80 and overBasic Helix-Loop-Helix ProteinsBone and BonesCartilageComputational BiologyExome SequencingFamilyFemaleFinlandHumansMaleMiddle AgedBasic Helix-Loop-Helix ProteinsFIP1L1 protein, humanmRNA Cleavage and Polyadenylation Factorsoligodendrocyte lineage transcription factor 3, humanRNA, Messenger

Identifiers

PMID30157244
PMCPMC6114922
OpenAlexW2889149681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.